← Eichor
Study identifier: NCT07295652 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders

Condition: Neurologic Disorders · Schizophrenia · Bipolar Disorder (BD)  ·  Sponsor: Centre Hospitalier St Anne

PhaseNA
Planned participants600
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Neuropsychiatric disorders are extremely common, severe, and disabling conditions. In the field of psychiatry, they notably include schizophrenia, mood disorders (depressive and bipolar disorders), autism spectrum or neurodevelopmental disorders, obsessive-compulsive disorder, eating disorders, and personality disorders. In the field of neurology, one can cite neurodegenerative diseases (such as Alzheimer's disease, but also frontotemporal dementia or Parkinson's disease, which often represent frequent and challenging differential diagnoses of psychiatric disorders), focal neurological lesions (notably strokes and tumors), or epilepsy. Cognitive impairments are present in nearly all neuropsychiatric disorders and contribute significantly to disability. While impairments in working memory and attention, executive functions, and social cognition have been relatively well studied, other cognitive domains remain largely unexplored in these populations. This is particularly the case for various aspects of motivation, metacognition, conscious access, or causal (Bayesian) inference. Although these domains likely play an important role in prognosis, no consensus currently exists regarding the methods for evaluating these functions. The main objective of this study is to define a multidimensional, transdiagnostic atlas of high-level cognitive impairments-both specific and shared-across severe psychiatric disorders (notably schizophrenia, depressive disorder, bipolar disorder, auti…

This description comes directly from the study's public registry record.

Talk to the study team

Jacob DHOTE, Dr  ·  +33 145658177  ·  j.dhote@ghu-paris.fr

Fabien VINCKIER, Pr  ·  F.VINCKIER@ghu-paris.fr

Always discuss trial participation with your own doctor first.

Locations (3)

Departement of Adult Psychiatry, GH Pitié SalpétrièreParis, FranceRecruiting
Groupe hospitalo-universitaire Paris Psychiatrie et NeurosciencesParis, FranceRecruiting
Hôpital Fondation Adolphe de RothschildParis, FranceNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07295652